Red Reef Laboratories and MyoTrend Nutritional Technologies – A Healthy Marriage
Synergy has a lot to do with a successful acquisition by a public company. In a perfect world, the marriage of management and products compliment each other, making the whole greater than the sum of its parts.
That’s exactly what we see taking place with the acquisition of MyoTrend Nutritional Technologies, Inc. by Red Reed Laboratories, Inc. another of our feature companies for this month at Real Stock Discoveries. Red Reef Laboratories International, Inc. (Pink Sheets: RRLB), is a diversified scientific research, development, and marketing group.
Under the direction of Dr. Claus Wagner-Bartak, CEO of Red Reef Labs has developed a family of products dedicated to assist sufferers with effective preparations specifically targeting suffers and those at risk for Diabetes Type 2 (also known as adult-onset diabetes), a rapidly growing medial problems today as America’s baby boom generation ages. It comprises of readily available supplements that may help with the known effects of this disease by enhancing insulin function and the possible reduction of insulin resistance without the potentially harmful side effects of “conservative” medication. The company has identified three markets for their products.
The first market contains people diagnosed with Type 2 Diabetes and those with a probability factor for future diagnosis. To address this market, Red Reef Labs has already developed 5 products which will be marketed under the brand name “Metabetics”. This suite of synergistic products are designed to assist in the management of symptoms and will be rolled out into the market in the very near future.
RRLB’s second market focuses on nutritional performance supplements for personal fitness and athletic training. The company has selected several key products in the areas of strength, conditioning and weight management for optimum health and performance. This line provides a significant opportunity for complimentary cross marketing with Myotrend.
The third market addressed by the Metabasics suite of products focuses on health and wellness lifestyle products for men; this line features sleek packaging to appeal to discriminating, active middle to upper income males.
While Red Reef Labs was focused on developing the Metabetics suite of products, MyoTrend Nutritional Technologies was likewise busy developing state of the art nutritional supplements which focus on enhancing health and human performance. Using one of the most demanding human laboratories, fitness and body building, MyoTrend Nutritional Technologies, has thrust itself into this niche and captured the attention and loyalty of amateurs and professionals alike. This unique setting has allowed the company to position itself on the leading edge of the nutritional supplement sciences.
By merging the intellectual talents of both teams working together, the new “dream team” has the ability to lead the industry forward with new breakthrough technologies and products and, by integrating MyoTrend’s advanced internet marketing strategies along with their existing brick and mortar supply chain, including the
world’s largest chain of healthfood stores and America’s largest manufacturer of nutritional supplements, GNC (General Nutrition Centers), the pending introduction of Red Reef Lab’s product lines has been propelled forward significantly.
Like we said at the beginning, this merger between Red Reef Laboratories and MyoTrend Nutritional Laboratories has all the earmarks of a total winner. By combining two highly compatible product lines then adding MyoTrend’s obvious talent at marketing both online and through traditional methods like GNC, which we consider to be a major coup, we expect to see RRLB’s Metabetics line on the shelves of GNC as well in short order. We’re excited about this one and encourage you to check Red Reef Laboratories, Inc out. The market is showing strong indications of getting ready to make a move so don’t hesitate on this one.
NOTE: We have been hired to feature RRLB on our website for 30 days. Please read our disclaimer for more information.
